This trial is active, not recruiting.
|Treatment||spectrum image analysis using a linear array ultrasound bronchoscope|
|Sponsor||University Health Network, Toronto|
|Start date||September 2013|
|End date||September 2016|
|Trial size||300 participants|
|Trial identifier||NCT01972386, 12-5898-CE|
To evaluate the clinical benefit of spectrum analysis of endobronchial ultrasound images of lymph nodes during EBUS TBNA for lymph node staging in patients with lung cancer.
Lymph Node Staging
time frame: Pathology report will be completed as soon as possible after the procedure. (Within one year)
Male or female participants at least 18 years old.
Inclusion Criteria: - Ages 18 years or older - Patients with known or suspected lung cancer who require EBUS-TBNA for lymph node staging Exclusion Criteria: - Patients who are deemed on clinical grounds not to be medically fit for a bronchoscopy - Inability to give informed consent - Patients who are pregnant
|Official title||Spectrum Image Analysis of Lymph Nodes During Endobronchial Ultrasound-Guided (EBUS) Transbronchial Needle Aspiration (TBNA) in Patients With Lung Cancer|
Call for more information